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AKI than the  MyD88  – / –  mouse 6,9 suggests 
that both MyD88-dependent and MyD88-
independent pathways are activated by 
TLR4 activation. Th is may also suggest 
diff erent ligand – TLR4 complexes coordi-
nating unique signaling cascades. 10 Th is 
is of potential importance because, as 
Chen  et al. 2 outline,  ‘ each ligand may acti-
vate its own TLR4-receptor complex and 
intracellular signaling pathways ’ and thus 
produce diff erent physiological results. 
Nonetheless, targeting the ligand – TLR4 
interaction may be a more fruitful thera-
peutic endeavor than targeting the down-
stream pathways in ischemic AKI. 
 In conclusion, Chen  et al. 2 have again 
brought the endothelium into the con-
versation as an important therapeutic 
target in AKI. Th e overall understanding 
of non-glomerular endothelial-cell biology 
and how it relates to kidney disease is still 
in a relatively early stage in comparison 
with other organs. Although studies such 
as the one highlighted here continue to 
make strides in our knowledge, there is 
still considerable progress to be made 
before this knowledge can be translated 
into meaningful therapeutic advances 
for AKI. 
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 Angiotensin II: breathtaking 
in the renal medulla 
 Volker H.  Haase 1 
 Angiotensin II (Ang II) is a major contributor to the progression of renal 
fibrosis. Wang and colleagues provide evidence that signaling through 
the prolyl-4-hydroxylase domain (PHD) – hypoxia-inducible factor-1 
(HIF-1) pathway mediates profibrotic effects of Ang II in rat renal 
medullary interstitial cells under normoxic conditions, thus placing the 
HIF oxygen-sensing pathway into the center of an Ang II-induced 
profibrotic signaling cascade. 
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 Aside from its potent hemodynamic 
eff ects, angiotensin II (Ang II) stimulates 
growth of diff erent renal cell types and 
increases the expression and synthesis of 
extracellular matrix proteins and various 
cytokines and chemokines, thus promot-
ing infl ammation and fi brosis. 1 In the con-
text of renal injury, it is a major contributor 
to the progression of chronic kidney dis-
ease. Ang II signals through two specifi c G 
protein-coupled receptors, the Ang II 
receptor type 1 (AT 1 ) and the Ang II recep-
tor type 2 (AT 2 ). Signaling through the 
AT 1 receptor mediates vasoconstriction 
and aldosterone release, stimulates tubular 
sodium transport, and promotes growth, 
infl ammation, and fi brosis, whereas AT 2 
signaling has been proposed to antagonize 
these AT 1 -mediated eff ects and is believed 
to protect from progression of chronic 
 kidney disease. Another major eff ect of 
AT 1 -receptor activation is the generation 
of reactive oxygen species (ROS). This 
occurs predominantly through activation 
of membrane-bound NADPH oxidase, 
which converts NADPH and molecular 
oxygen to NADP   +   and superoxide anions 
(reviewed by Sachse and Wolf  2 ). 
 Now, Wang and colleagues 3 (this issue) 
demonstrate that Ang II-induced ROS 
generation leads to non-hypoxic stabiliza-
tion of the oxygen-sensitive   -subunit of 
hypoxia-inducible factor (HIF)-1 in rat 
renal medullary interstitial cells, which in 
turn is required for Ang II-stimulated col-
lagen I / III and tissue inhibitor of metal-
loproteinases (TIMP)-1 synthesis, thereby 
placing HIF-1 into the center of an Ang 
II-induced profi brotic signaling cascade 
( Figure 1 ). HIF-1  stabilization was, fur-
thermore, necessary for Ang II-induced 
growth and vimentin expression. While 
treatment with Ang II also led to increased 
HIF-2  expression, inactivation of HIF-
2  , in contrast to HIF-1  knockdown, 
did not signifi cantly aff ect Ang II-induced 
TIMP-1 or collagen I / III levels. 
 HIF-1 and HIF-2 are basic helix-loop-
helix transcription factors that consist of 
an oxygen-sensitive   -subunit and a 
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constitutively expressed   -subunit, also 
known as the aryl hydrocarbon receptor 
nuclear translocator (ARNT). Although 
HIF-  is continuously synthesized, it is 
rapidly degraded under normoxia. Th is 
requires hydroxylation of specifi c proline 
residues within the oxygen-dependent 
degradation domain of HIF-  , enabling 
interaction with the von Hippel – Lindau –
 E3 ubiquitin ligase complex, which then 
tar gets HIF for rapid proteasomal degra-
dation (reviewed by Kaelin and Ratcliff e 4 ) 
( Figure 1 ). Th e hydroxylation reaction 
is dependent on molecular oxygen, fer-
rous iron, and ascorbate and is carried 
out by 2-oxoglutarate-dependent dioxy-
genases (prolyl-4- hydroxylase domain 
(PHD) proteins). Three major HIF-
hydroxylating enzymes have been iden-
tifi ed, PHD1, PHD2, and PHD3, of which 
PHD2 is the main dioxy genase for HIF 
degradation under normoxia. Th e three 
PHD proteins diff er with regard to their 
cellular expression levels, intracellular 
localization, hypoxia-inducibility, and 
biochemical behavior (reviewed by 
Kaelin and Ratcliff e 4 ). In the kidney, all 
three enzy mes are expressed in a cell 
type-dependent manner. 5 
 Th e role of HIF-1 in renal injury is highly 
context- and cell type-dependent. Whereas 
HIF-1 confers cytoprotection in the acute 
setting, there is now growing evidence that 
HIF-1 activation under certain chronic 
disease conditions can promote fi brosis in 
the kidney and in other organs. 6 Th is was 
recently demonstrated in transgenic and 
conditional knockout mice 7,8 and may 
occur through increased expression of 
extracellular matrix-modifying genes, such 
as lysyl-oxidases and plasminogen activa-
tor inhibitor-1; functional cooperation with 
transforming growth factor-  1; promotion 
of epithelial-to-mesenchymal transition; 
and the modulation of renal infl ammation. 
Increased HIF expression has been found 
in animal models of chronic kidney disease 
and in renal biopsy material from patients 
with diabetic nephropathy and other forms 
of renal disease, where it correlates with 
disease severity. 7,9,10 Stabilization of HIF-  
in this context is thought to be due to 
hypoxia, which results from a combination 
of structural and functional changes that 
are commonly found in fi brotic kidneys. 
These include decreased peritubular 
blood fl ow associated with glomerular 
injury, capillary rarefaction, vasoconstric-
tion, luminal narrowing of atherosclerotic 
vessels, increased oxygen demand from 
hyperfi ltration and tubular hypertrophy, 
limited oxygen diff usion as a consequence 
of extracellular matrix expansion, and 
renal anemia. 9 
 It has been known for some time that 
Ang II can act as a hypoxia mimetic, 
stabilizing HIF-1  in vascular smooth 
muscle cells under normoxic condi-
tions. 11 Th is results primarily from HIF 
prolyl-4-hydroxylase inhibition, which 
is due to increased ROS generation and 
diminished intracellular ascorbate lev-
els, leading to the oxidation of a critical 
iron atom that is positioned in the center 
of  the PHD catalytic  domain.  12 
Although Ang II-generated ROS appear 
to be largely derived from the activation 
of NADPH oxidase, 2 more recent stud-
ies suggest that Ang II-induced HIF-1  
stabilization may be mediated by mito-
chondrial ROS. 13 Although initially 
heavily debated, the importance of 
mitochondrial ROS in the modulation 
of molecular oxygen sensing and regula-
tion of HIF activity has been recently 
demonstrated by elegant genetic, phar-
macological, and RNA interference-
based studies. 14 – 16 Wang and colleagues 3 
(this issue) take the Ang II – HIF connec-
tion one step further and investigate 
whether the PHD – HIF pathway is part 
of an Ang II-induced profi brotic signal-
ing cascade in the kidney. Although 
their studies are mainly  in vitro -based, 
the authors provide supporting  in vivo 
evidence and show that Ang II infusion 
over a period of 2 weeks resulted in 
HIF-1  stabilization in renal medullary 
cells, which was associated with an 
increase in    -smooth muscle actin 
expression. However, additional studies 
are warranted that assess the relative 
contribution of Ang II-induced hemody-
namic alterations to HIF-1  stabilization 
in the kidney. 17 Once activated, HIF-1  
either acts as a transcription factor that 
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 Figure 1  |  Angiotensin II stabilizes hypoxia-inducible factor-1  in renal medullary 
interstitial cells . Angiotensin II (Ang II) stimulates the production of reactive oxygen species 
(ROS). This leads to the inhibition of the hypoxia-inducible factor (HIF)-hydroxylation reaction 
and subsequent stabilization of HIF-1  . HIF-1  is required for Ang II-induced profibrotic gene 
expression and proliferation of renal medullary interstitial cells. Under normoxia, HIF-1  is 
normally hydroxylated by prolyl-4-hydroxylases and targeted for proteasomal degradation 
by the von Hippel-Lindau (pVHL) – E3 ubiquitin ligase complex. When prolyl-4-hydroxylation is 
inhibited, HIF-1  is stabilized and translocates to the nucleus, where it heterodimerizes with the 
aryl hydrocarbon receptor nuclear translocator (ARNT). HIF-1  – ARNT heterodimers bind to the 
HIF consensus-binding site RCGTG, followed by transactivation of target genes. In addition to 
ROS, nitric oxide, the Krebs cycle metabolites succinate and fumarate, cobalt chloride, and iron 
chelators such as desferrioxamine inhibit HIF prolyl-4-hydroxylases in the presence of oxygen. 
CoCl 2 , cobalt chloride; Fe 
2  +   , ferrous iron; NO, nitric oxide; P-4-HD, prolyl-4-hydroxylases; TIMP-1, 
tissue inhibitor of metalloproteinases-1. 
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binds to a specifi c DNA sequence, which 
is contained within a hypoxia-response 
element (HRE), or it interacts with other 
signaling molecules outside the nucleus. 6 
Although Wang and colleagues 3 demon-
strate that HIF-1  is required for Ang 
II-induced profi brotic eff ects, it remains 
to be determined to what degree this 
involves HRE-mediated transcription; 
for example, TIMP-1 contains a HIF-
binding site in its regulatory region. 18 
Furthermore, it would be important to 
defi ne which other HIF-controlled bio-
logical responses are activated by Ang II 
alone as compared to hypoxic stimulation. 
In this context it is worth pointing out 
that hypoxia and Ang II do not appear to 
act synergistically in the study by Wang 
and colleagues. 3 
 In a second set of experiments, Wang 
and colleagues 3 demonstrate that Ang II 
reduces HIF-1   hydroxylation and 
investigate whether manipulations of 
PHD2 expression levels modulate Ang 
II-induced collagen I / III and TIMP-1 
synthesis. PHD2 is critically important 
for HIF degradation under normoxia, as 
genetic inactivation of PHD2 results in 
embryonic lethality. 4 As predicted, an 
increase in PHD2 levels reduced colla-
gen I / III and TIMP-1 expression in the 
presence of Ang II, whereas PHD2 
knockdown had the opposite effect. 
Whether pharmacological inhibition of 
PHD enzymes, which is currently being 
evaluated in clinical trials as a new 
modality for the treatment of renal ane-
mia, has the same effect on the renal 
medullary interstitial cells  in vivo is 
unclear and warrants further investiga-
tion. Interestingly, immunohistochemical 
analysis of renal PHD expression did not 
visualize PHD2 protein in non-endothe-
lial interstitial cells, whereas both PHD1 
and PHD3 enzymes were easily detecta-
ble. 5 While it is unclear whether there are 
regional diff erences in interstitial PHD2 
expression, it is plausible that, with 
regard to HIF stabilization, cells that 
express little or reduced amounts of 
PHD2 become more susceptible to 
changes in intracellular ascorbate and / or 
ROS concentrations. To what degree 
PHD1 and PHD3 contribute to Ang II-
stimulated collagen I / III and TIMP-1 
synthesis remains to be investigated. Th is 
is particularly important with regard to 
PHD3, which is hypoxia-inducible and 
HIF-regulated and is part of a negative-
feedback loop. PHD3 protein levels are 
predicted to increase when HIF-1 is acti-
vated, which could lead to a reduction in 
collagen I / III and TIMP-1 expression 
over time. A time course study should be 
able to clarify this issue. Diff erences in 
PHD levels between various renal cell 
types may also explain why, in contrast 
to hypoxia and iron chelation, treatment 
of human renal cortical fi broblasts with 
H 2 O 2 did not produce an increase in 
TIMP-1 or collagen I expression. 18 
 In summary, Wang and colleagues 3 link 
profi brotic eff ects of Ang II in the kidney 
to the PHD – HIF molecular oxygen-sens-
ing pathway. Th eir fi ndings not only pro-
vide novel insights into angiotensin 
biology but also lend further support to 
the concept that activation of HIF signal-
ing in the kidney can occur in the absence 
of signifi cant hypoxia. Th e paper by Wang 
and colleagues 3 provokes future studies 
that investigate the Ang II – PHD – HIF axis 
in other renal cell types and in the context 
of acute and chronic kidney injury. 
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